National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 41975 [2023-13725]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 123 / Wednesday, June 28, 2023 / Notices
Dr.
Joshua Denny AOUTribal@nih.gov, 301–
827–9737. More information is available
at https://allofus.nih.gov/
tribalengagement. The All of Us Tribal
Engagement team may also be reached
by email at AOUTribal@nih.gov, or by
mail at All of Us Research Program,
Division of Engagement and Outreach,
Tribal Engagement, NIH, 6710–B
Rockledge Drive, 4th Floor, Bethesda,
MD 20817.
SUPPLEMENTARY INFORMATION:
FOR FURTHER INFORMATION CONTACT:
I. Background Information
The All of Us Research Program aims
to accelerate health research and
medical breakthroughs to enable an era
of precision medicine for all. All of Us
is committed to ensuring the program
reflects the diversity of the United
States.
In the 21st Century Cures Act (Pub. L.
114–255), Congress authorized NIH to
carry out the Precision Medicine
Initiative, which includes the All of Us
Research Program. The law provides
NIH with critical tools and resources to
advance biomedical research across the
spectrum, from foundational basic
research studies to advanced clinical
trials of promising new therapies, in
part through the establishment of a
diverse cohort of individuals to support
the goals of All of Us.
II. Tribal Virtual Informational
Presentations and Discussions With
Tribal Communities
In June 2023, All of Us held four
information and discussion sessions
virtually to continue to engage with
Tribal Nations and rural and urban AI/
AN communities. Recorded sessions
will be made available at https://
allofus.nih.gov/about/diversity-andinclusion/tribal-engagement.
ddrumheller on DSK120RN23PROD with NOTICES1
III. Questions
A. Management and Sharing of SelfIdentified AI/AN Data (Without Tribal
Affiliation)
1. Integrating information from selfidentified AI/AN participants in our
data platform, the All of Us Research
Hub at https://www.researchallofus.org.
(a) How can the program augment the
current policies and protections for selfidentified AI/AN participant data so
that it can be shared with researchers?
(b) What additional policies or
guidance would you like All of Us to
consider around the use of data from
self-identified AI/AN participants?
2. Honoring Tribal sovereignty when
working with self-identified AI/AN
individuals who consent to participate.
(a) What kinds of protective practices
and measures can be implemented to
VerDate Sep<11>2014
20:02 Jun 27, 2023
Jkt 259001
avoid infringing upon Tribal sovereignty
when collecting or working with
individual participant data?
(b) How should the program manage
and share data from self-identified AI/
AN individuals who choose to
participate in the program, including
those who are living off Tribal lands
and/or who are not affiliated with a
federally recognized Tribe?
B. Tribal Engagement and Outreach
1. Possible future marketing efforts in
zip codes that overlap on Tribal land
and areas bordering Tribal land.
(a) How should the program guide
engagement and outreach efforts where
zip codes overlap with Tribal land?
2. Program activities for individual
participants on Tribal land.
(a) What protocol should be followed
when individual participants request
program materials to be mailed to them
or request home visits on Tribal lands?
C. Program Planning Activities
1. Future inclusion of children in the
All of Us Research Program.
(a) What unique considerations are
there for the future inclusion of AI/AN
infants, children, and adolescents as
participants in the program, given that
a child’s parent or legal guardian must
be a current participant?
(b) What unique considerations are
there for family-based enrollment in the
research program (e.g., parent or legal
guardian participating with their child)?
(c) What specific factors should be
taken into account when enrolling
families in the research program,
considering the possibility of kinship
caregivers or non-traditional child care
arrangements for the child?
2. AI/AN traditional blessing
ceremony for biosamples of participants
who withdraw from the program.
(a) How should the program proceed
in conducting a traditional blessing
ceremony for the participants who selfidentify as AI/AN and request a blessing
ceremony prior to the biosample
disposition?
Dated: June 22, 2023.
Tara A. Schwetz,
Acting Principal Deputy Director, National
Institutes of Health.
[FR Doc. 2023–13750 Filed 6–27–23; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
41975
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIH Support for
Conferences and Scientific Meetings (Parent
R13 Clinical Trial Not Allowed).
Date: August 1–2, 2023.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G11,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Barry J. Margulies, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G11, Rockville, MD
20852, (301) 761–7956, barry.margulies@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: June 23, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–13725 Filed 6–27–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
Frm 00102
Fmt 4703
Sfmt 4703
E:\FR\FM\28JNN1.SGM
28JNN1
]]>Agencies
[Federal Register Volume 88, Number 123 (Wednesday, June 28, 2023)]
[Notices]
[Page 41975]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-13725]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIH Support for Conferences and
Scientific Meetings (Parent R13 Clinical Trial Not Allowed).
Date: August 1-2, 2023.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G11,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Barry J. Margulies, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G11,
Rockville, MD 20852, (301) 761-7956, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: June 23, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-13725 Filed 6-27-23; 8:45 am]
BILLING CODE 4140-01-P
